Sleuthy Google up­start Cal­i­co forges a rare biotech col­lab­o­ra­tion on ag­ing with No­var­tis-backed C4

The elu­sive but wide­ly buzzed about Cal­i­co, a start­up bankrolled by Google to find new ther­a­pies for ag­ing, has hitched up with pro­tein de­gen­er­a­tion-fo­cused C4 Ther­a­peu­tics with plans to em­bark on a 5-year, cross coun­try re­search col­lab­o­ra­tion.

The deal an­nounce­ment is long on over­ar­ch­ing goals, such as a pre­clin­i­cal fo­cus on can­cer, among oth­er ar­eas, but with lit­tle in­sight in­to the num­bers or the work. And that’s just the way Cal­i­co likes to keep it, care­ful­ly cloak­ing its ac­tiv­i­ties more like an IT com­pa­ny than any av­er­age biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER